Latest News Archive
Please select Category, Year, and then Month to display items
30 May 2025
|
Story Prof Mikateko Mathebula
|
Photo Supplied
Pictured (from left to right): Prof Faith Mkwananzi, Dr Kapambwe Mwelwa, Prof Lochner Marais, Prof Chikumbutso Manthalu, and Prof Mikateko Mathebula.
Through collaborative agreements with the University of Malawi and the University of Zambia, the University of the Free State (UFS) has established the Research Alliance for Higher Education in Africa (RAHEdA), a dynamic initiative aimed at enhancing research capacity and partnerships within Sub-Saharan Africa.
The collaborative agreements align with the UFS’s Vision 130 strategy in relation to internationalisation, emphasising the important role that intra-African mobility visits play in establishing relationships with universities on the continent. It also fosters knowledge exchange and engagement and allows for careful planning and strategy meetings.
“During these discussions, an ambitious but feasible roadmap was laid out for the next three to five years,” Prof Mkwananzi said. “These activities include online workshops for staff and postgraduate students at all partner institutions, and a new webinar series that focuses on profiling, advancing, and celebrating thought leaders, higher education scholars, and scholarship in Africa.”
The inaugural webinar was held on 21 May 2025. Speaker Prof Siseko Kumalo, Associate Professor at the University of Johannesburg’s Ali Mazrui Centre for Higher Education Studies, spoke on ‘Orality as the Bulwark of the Humanities?’, set the bar high for the webinar series through his compelling and original response to this timely question, as scholars around the world contemplate appropriate responses to the rise and influence of artificial intelligence in higher education teaching, learning, and assessment.
Funding to support RAHEdA has been generously provided by Prof Melanie Walker, Distinguished Professor and SARChI Chair in Higher Education and Human Development.
• For information on how to get involved and for updates on RAHEdA, please contact Prof Mikateko Mathebula at MathebulaM@ufs.ac.za
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004